Sort   by:  
 Page size 
UnknownWeekly docetaxel and gemcitabine in previously treated metastatic esophageal squamous cell carcinoma.
Not available
S-EPMC4394089 | biostudies-literature
UnknownmTORC1/2 inhibitor and curcumin induce apoptosis through lysosomal membrane permeabilization-mediated autophagy.
Not available
S-EPMC6147804 | biostudies-literature
UnknownPhosphorylation of OTUB1 at Tyr 26 stabilizes the mTORC1 component, Raptor.
Not available
S-EPMC9883261 | biostudies-literature
UnknownAxl Inhibitor R428 Enhances TRAIL-Mediated Apoptosis Through Downregulation of c-FLIP and Survivin Expression in Renal Carcinoma.
Not available
S-EPMC6651098 | biostudies-literature
UnknownCathepsin K inhibition-induced mitochondrial ROS enhances sensitivity of cancer cells to anti-cancer drugs through USP27x-mediated Bim protein stabilization.
Not available
S-EPMC6948260 | biostudies-literature
UnknownDexamethasone Inhibits TRAIL-Induced Apoptosis through c-FLIP(L) Upregulation and DR5 Downregulation by GSK3β Activation in Cancer Cells.
Not available
S-EPMC7600459 | biostudies-literature
UnknownBAP1 phosphorylation-mediated Sp1 stabilization plays a critical role in cathepsin K inhibition-induced C-terminal p53-dependent Bax upregulation.
Not available
S-EPMC9117696 | biostudies-literature
UnknownInhibition of cathepsin K sensitizes oxaliplatin-induced apoptotic cell death by Bax upregulation through OTUB1-mediated p53 stabilization in vitro and in vivo.
Not available
S-EPMC8782718 | biostudies-literature
UnknownThioridazine enhances sensitivity to carboplatin in human head and neck cancer cells through downregulation of c-FLIP and Mcl-1 expression.
Not available
S-EPMC5386499 | biostudies-literature
UnknownCathepsin D as a potential therapeutic target to enhance anticancer drug-induced apoptosis via RNF183-mediated destabilization of Bcl-xL in cancer cells.
Not available
S-EPMC8816936 | biostudies-literature
Sort   by:  
 Page size